|Bid||0.4850 x 0|
|Ask||0.4800 x 0|
|Day's Range||0.4950 - 0.4950|
|52 Week Range||0.3200 - 1.0000|
|Beta (3Y Monthly)||3.15|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||1.50|
LONDON, ON , May 10, 2019 /CNW/ - INDIVA Limited (the "Company" or "INDIVA") (NDVA.V) is pleased to announce that the Company has granted 810,000 incentive stock options (the "Options") to certain employees and an executive officer. The Company's Stock Option Plan allows for the issuance of up to 10% of issued and outstanding share capital in the form of incentive stock options. As a result of this grant, the Company has a total of 5,033,315 stock options issued, representing approximately 6% of the issued and outstanding share capital.
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! We often see insiders buying up shares in companies that perform well over the long term. Unfortunately...
LONDON, ON , May 1, 2019 /CNW/ - Indiva Limited (the "Company" or "Indiva") (NDVA.V) (NDVAF) is pleased to report results for the year ended December 31, 2018 . For the fourth quarter and year-ended December 2018 , Indiva reported $58,307 of net revenue, versus nil in 2017 and nil in Q3 2018. Revenue was derived almost entirely from wholesale sales of cannabis flower and clones, as Indiva's contract with the OCS did not begin until Q1 2019.
Although often overshadowed by the importance of marijuana retail and branding, cannabis extraction is a vital component of any vertically integrated cannabis company. Not only do in-house extraction operations allow cannabis companies to avoid outsourcing costs, but it also enables the potential for additional revenue streams and more rapid product ideation. With cannabis edibles, extracts, and topicals expected to be legal in the Canadian market later this year, we examine some of the marijuana industry’s largest cannabis extractors.
SEATTLE, March 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering Indiva Inc’s (NDVA.V) strategic position in the extracts market. As the cannabis industry matures, extraction is becoming an increasingly important part of any successful venture, as consumers have proven they are more interested in derivative products than simply smoking flower. According to Health Canada figures, cannabis oil in Q1 2018, months before the legalization of recreational cannabis, outsold flower by 56 per cent as medicinal patients looked to concentrates to alleviate a range of symptoms from chronic pain to seizures, and health practitioners preferred concentrates which enable more accurate dosing.
LONDON, ON , March 11, 2019 /CNW/ - Indiva Limited (the "Company" or "Indiva") (NDVA.V) (NDVAF) is pleased to provide an update on the design of its extraction facility in London, Ontario . "Indiva's plan to perform extraction on site in order to complement third party extraction services is founded in our commitment to provide high quality oils, concentrates and edibles to our patients and clients when permitted under Canadian law. We are delighted with the work Lucid Lab Group has completed, and the tremendous excess extraction capacity opens the door to several options to grow our revenue base and lower our unit costs," said Niel Marotta , President and CEO of Indiva.
LONDON, ON , March 1, 2019 /CNW/ - Indiva Limited (the "Company" or "Indiva") (NDVA.V) (NDVAF) Is pleased to report that INDIVATM pre-rolls are now available through the Ontario Cannabis Store. Indiva is currently offering two strains: an indica called LA Confidential and a sativa named Ghost Train Haze. INDIVATM pre-rolls are hand-made, hand-weighed and crafted with care. "I am very proud of the team at Indiva. I am inspired and grateful to work with such an amazing group of professionals who have dedicated themselves to a level of care in their craft which is clearly evident in the quality of Indiva's products," said Niel Marotta , President and CEO of Indiva. Indiva aims to become a house of global marijuana brands, recognized for high quality cannabis products.
The retrofit of 3 additional flower rooms is now complete and are currently undergoing standard cleaning and sanitization procedures. The final video evidence package was submitted to Health Canada on January 21st . Once licensed by Health Canada, these 3 new rooms will immediately be populated with plants currently growing in Indiva's facility, and increase Indiva's annual dry flower capacity to 1,000kg. By the end of Q2, Indiva expects that dry flower capacity will increase to some 3,000kg annually with the licensing of 5 additional flower rooms. With the $5.55 million cash purchase of the property, Indiva now has secured long-term certainty for the home of the organization's operations. Further, by owning the property it allows Indiva a greater ability for potential debt financing options in the future and has streamlined the process behind the planned creation of the Indiva farmgate store (subject to AGCO approval).
Bhang Corporation ("Bhang" or the "Company") announced today that it will host educational and sensory sessions in Toronto in advance of cannabis edibles legalization, to provide cannabis consumers the opportunity to familiarize themselves with the Bhang product line and ask questions about proper edibles usage. To bring Canadians innovative cannabis products, Bhang partnered with Indiva Limited (Indiva) (NDVA.V) (NDVAF) to manufacture and distribute Bhang cannabis products in Canada.
SEATTLE, Feb. 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering Indiva Limited’s new supply agreement. INDIVA Limited (NDVA.V), a London, Ontario licensed supplier of high quality medical-grade cannabis, announced February 8th that it has inked its first supply agreement with the Ontario Cannabis Retail Corporation, consisting of two strains of pre-rolls for sale through the Ontario Cannabis Store.
LONDON, ON , Feb. 8, 2019 /CNW/ - Indiva Limited (the "Company" or "Indiva") (NDVA.V) (NDVAF) is excited to announce its first supply agreement with the Ontario Cannabis Retail Corporation ("OCRC"), doing business as the Ontario Cannabis Store ("OCS"). This initial partnership will consist of two strains of pre-rolls, manufactured and shipped with care from Indiva's London, Ontario facility. The products will be available on OCS.ca and to OCS Wholesale clients starting in April 2019 .
SEATTLE, Feb. 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering INDIVA Limited (NDVA.V). The company went public in December of 2017, currently has $24 million on the balance sheet with a $46 million market cap, and its fully-funded facility expansion project is nearing completion.
LONDON, ON , Jan. 31, 2019 /CNW/ - Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA.V) (NDVAF) has further solidified its commitment to the upcoming cannabis derivatives and edibles market by hiring Lucid Lab Group to design the Company's planned extraction facility. The facility, which is planned for Q2 2019, will be the hub of oil manufacturing and product innovation for all of Indiva's related cannabis products, including tinctures and gel capsules, as well as licensed products such as Bhang Chocolate, Ruby Sugar and Ruby Chewable Gems.
LONDON, ON , Jan. 22, 2019 /CNW/ - Indiva Limited (the "Company" or "Indiva") (NDVA.V) (NDVAF) is pleased to announce it has completed a 9.9% equity investment into RetailGo Inc (or "RGI"). Indiva will contribute leases for 10 proposed retail locations in Ontario , and will receive a 5-year promissory note in the amount of $730,000 , plus an additional $300,000 to be repaid separately, representing funds committed to date. RetailGo Inc will be managed by Koby Smutylo , who has resigned from his position as COO and Director of Indiva, effective immediately, in order to focus his efforts on RGI. Koby is a co-founder of Indiva. The Indiva board would like to thank Koby for his efforts and contribution, and wish him well in his new endeavour. Indiva's wholly owned subsidiary is licensed under the Cannabis Act and is a supplier of high quality, medical grade cannabis and cannabis products. Indiva's mission is to offer cannabis products that have a positive impact, improving lives and communities.
LONDON, ON , Dec. 13, 2018 /CNW/ - Indiva Limited (the "Company" or "Indiva") (NDVA.V) (NDVAF) is pleased to announce it has successfully imported 3 premium CBD strains from Swiss cannabis producer Medropharm GmbH and Greenfields Health Care S.A. Having entered a strategic cooperation with the Swiss producer in 2017, Indiva's CEO Niel Marotta has announced that the London -based company now has tissue cultures of the 3 strains propagating in their growth chamber. "We are proud to be the exclusive Canadian producer of these CBD strains, and pleased to enjoy a symbiotic relationship with Medropharm and Greenfields," says Marotta. "Like Indiva, our Swiss partners are known for their commitment to improving their customers' health and quality of life," notes Marotta.
The global legal cannabis market is projected to hit $146.4 billion by end of 2025, according to research by Grand View Research. The legal cannabis industry is gaining traction worldwide due to high demand among consumers for recreational and medical products. Recreational cannabis spending is projected to hit $35 Billion mark, while medical cannabis spending […] The post Cannabis Stock News Daily Roundup November 28 appeared first on Market Exclusive.
LONDON, ON , Nov. 27, 2018 /CNW/ - Indiva Limited (the "Company" or "Indiva") (NDVA.V) (NDVAF) is pleased to announce that just in time for the holiday gift-giving season, Indiva, licensed producer of medical-grade cannabis, has launched an e-commerce store for accessories on their website. "We couldn't be more thrilled to announce that our e-store is open for business," says Niel Marotta , President and CEO of Indiva.
LONDON, ON , Nov. 21, 2018 /CNW/ - Indiva Limited (the "Company" or "Indiva") (NDVA.V) (NDVAF) is pleased to announce it has signed a non-binding letter of intent ("LOI") with AEssense Europe for the acquisition of 100% of a medical cannabis cultivation and handling license in Denmark under the Danish Medicines Agency development scheme. AEssense Europe received its license from the Danish Medicines Agency on January 12, 2018 . The acquisition will be funded with a combination of 1.6 million Indiva common shares plus US$1.1 million in cash, payable over three years. Indiva will pursue the cultivation and worldwide distribution of EU-GMP certified medical cannabis and cannabis-derived products. Indiva intends to incorporate a wholly-owned subsidiary, Indiva Europe, which will be responsible for financing and managing the European operations.